The Combination of Probiotic and Calcium Carbonate Decrease Monocyte Count of End-Stage Renal Disease Patient

Ari Yulistianingsih, Mohammad Sulchan, Taufik Maryusman, Shofa Chasani

Abstract

Elevated monocyte count is correlated to the decrease of renal function and disease progressivity on end-stage renal disease (ESRD) patients. Probiotic that utilize lactobacillus species is known to play a role in maintaining imunity system balance by inducing the monocyte apoptosis. The combination between probiotic and calcium carbonate could increase probiotic colonization in the gatrointestinal tract. The aim of this study was to analyze the effect of probiotic and calcium carbonate combination toward reduction of monocyte count on ESRD patient at Rumah Sehat Terpadu Dompet Dhuafa Bogor Hospital. This study was true experimental research with randomized pre-post test control group design. Twenty four ESRD patient were randomly enrolled into treatment group (n=12) and control (n=12). The treatment group received probiotic and calcium carbonate, whereas control group received standardized calcium carbonate for 21 days. There was a significant decrease of monocyte (p=0.03) after administration of probiotic and calcium carbonate.

Keywords

probiotic, calcium carbonate, monocyte count, end-stage renal disease

Full Text:

PDF

References

Akoglu, B., et al. 2015. Probiotic Lactobacillus casei Shirota Improves Kidney Function, Inflammation and Bowel Movements in Hospitalized Patients with Acute Gastroenteritis – A Prospective Study. Journal of Functional Foods, 17: 305–313.

Bohlke, M., et al. 2008. Predictors of Quality of Life among Patients on Dialysis in Southern Brazil. São Paulo Medical Journal Revista Paulista de Medicina, 126 (5): 252–6.

Cohen, G., and Hörl, W. H. 2012. Immune dysfunction in Uremia-An update. Toxins, 4 (11): 962–990.

Dahl, W. J., et al. 2016. Calcium Phosphate Supplementation Increases Faecal Lactobacillus spp. in a randomised trial of young adults. Beneficial Microbes, 7 (1): 3–10.

Delcenserie, V., et al. 2008. Immunomodulatory Effects of Probiotics in the Intestinal Tract. Curr Issues Mol Biol, 10 (1–2): 37–54.

Ganda, A., et al. 2013. Mild Renal Dysfunction and Metabolites Tied to Low HDL Cholesterol are Associated with Monocytosis and Atherosclerosis. Circulation, 127 (9): 988–996.

Ghattas, A., et al. 2013. Monocytes in Coronary Artery Disease and Atherosclerosis: Where are We Now? Journal of the American College of Cardiology, 62 (17): 1541–1551.

Gleeson, M., Bishop, N. C., Oliveira, M., and Tauler, P. 2011. Daily probiotic’s (Lactobacillus casei Shirota) Reduction of Infection Incidence in Athletes. International Journal of Sport Nutrition and Exercise Metabolism, 21 (1): 55–64.

Houtkooper, L., Farrell, V., and Mullins, V. 2017. Calcium Supplement Guidelines. College of Agriculture and Life Sciences, 1–4.

Hsu, C., et al. 2006. Body Mass Index and Risk for End-Stage Renal Disease. Annals of Internal Medicine, 144 (1): 21–8.

Inker, L. A.,, et al. 2014. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. American Journal of Kidney Diseases, 63 (5): 713–735.

IRR. 2014. Report of Indonesian Renal Registry 2014.

Jha, V.,, et al. 2013. Chronic Kidney Disease: Global Dimension and Perspectives. The Lancet, 382 (9888): 260–272.

K Gogineni, V., and Morrow, L. E. 2013. Probiotics: Mechanisms of Action and Clinical Applications. Journal of Probiotics & Health, 1 (1): 1–11.

Kataoka, Y., et al. 2013. Synbiotics Reduce Infectious Complications by Improving the Intestinal Milieu and Enhancing the Immune Function in Critically Ill Emergency Surgical Patients. Kitasato Med J, 43: 17–25.

Kusumaningsih, T. 2014. Peran Bakteri Probiotik terhadap Innate Immune Cell (The Role of Probiotic Bacteria on Innate Immune Cells). Oral Biology Journal, 6 (2): 45–50.

Mafra, D., et al. 2014. Role of Altered Intestinal Microbiota in Systemic Inflammation and Cardiovascular Disease in Chronic Kidney Disease. Future Microbiology, 9 (3): 399–410.

Manley, K. J., et al. 2007. Probiotic Treatment of Vancomycin-Resistant Enterococci: A Randomised Controlled Trial. Medical Journal of Australia, 186 (9): 454–457.

Ranganathan, N., et al. 2013. Nephrology & Therapeutics Dose Escalation, Safety and Impact of a Strain-Specific Probiotic (Renadyl TM) on Stages III and IV Chronic Kidney Disease Patients. Nephrology and Therapeutics, 3 (3): 1–9.

Seifert, S., Bub, A., Franz, C. M. A. P., and Watzl, B. 2011. Probiotic Lactobacillus casei Shirota Supplementation Does Not Modulate Immunity in Healthy Men with Reduced Natural Killer Cell Activity. The Journal of Nutrition, 141 (5): 978–984.

Skrzypczak, K., Gustaw, W., and Waśko, A. 2015. Health-Promoting Properties Exhibited by Lactobacillus Helveticus Strains. Acta Biochimica Polonica, 62 (4): 713–720.

Steiber, A. L., and Kopple, J. D. 2011. Vitamin Status and Needs for People with Stages 3-5 Chronic Kidney Disease. Journal of Renal Nutrition, 21 (5): 355–368.

Sulistiowati, Eva. Idaiani, Sri. 2015. Faktor Risiko Penyakit Ginjal Kronik Berdasarkan Analisis Cross-sectional Data Awal Studi Kohort Penyakit Tidak Menular Penduduk Usia 25-65 Tahun di Kelurahan Kebon Kalapa, Kota Bogor Tahun 2011. Buletin Penelitian Kesehatan, 43 (3): 163–172.

Supriyadi, Wagiyo, dan Ratih Widowati, S. 2013. Tingkat Kualitas Hidup Pasien Gagal Ginjal Kronik Terapi Hemodialisis. Jurnal Kesehatan Masyarakat, 8 (2): 113–120.

USRDS. 2016. 2015 USRDS Annual Data Report Volume 2: Epidemiology of Kidney Disease in the United States. United States Renal Data System, 2: 1–274.

Yani, A., Nugraha, G. I., and Marhaeni, D. 2017. Analysis of Nutrition Care Chronic Renal Failure Patients with Health Technology Assessment. Jurnal Kesehatan Masyarakat, 13 (272): 96–105.

Zhao, X., Zhang, Y., and Li, D. 2009. Elimination of Acidic or Oxidative Stress for Four Probiotics with Some Chemicals in Vitro. African Journal of Microbiology Research, 3 (7): 353–357.

Refbacks

  • There are currently no refbacks.